Healthcare -
Biotechnology - NASDAQ - US
$ 6.43
-2.43 %
$ 2.47 B
Market Cap
-3.8
P/E
RXRX - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities RXRX - Recursion Pharmaceuticals, Inc.
140 M
LAST VALUE
-44.72%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR